Screener
Mirum Pharmaceuticals, Inc. MIRM Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s invested capital?
- Mirum Pharmaceuticals, Inc. (MIRM) reported invested capital of -$260.24M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s invested capital decreased by 439.1% year-over-year, from $76.75M to -$260.24M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s invested capital has grown at a 16.0% compound annual growth rate (CAGR), from $33.27M to $69.97M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Mirum Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude